Paper Details

  1. Home
  2. Paper Details

Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT).

Author: , DanielEbenezer, FerrisFrederick L, GrunwaldJuan E, HuangJiayan, JaffeGlenn J, MaguireMaureen G, MartinDaniel F, TothCynthia A, YingGui-shuang

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Overview

This study found that visual acuity response at week 12 was more predictive of 2-year vision outcomes in patients with age-related macular degeneration (AMD) than baseline characteristics or week 4 response. Eyes with poor initial response may benefit from continued treatment with the same drug and regimen without switching to another drug.
Paper Details　
Original Abstract of the Article :
PURPOSE: To evaluate the association of baseline characteristics and early visual acuity (VA) response with visual outcomes at years 1 or 2 in the Comparison of Age-Related Macular Degeneration (AMD) Treatments Trials (CATT). DESIGN: Secondary analysis of CATT. PARTICIPANTS: The 1185 CATT particip...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/26383996

データ提供：米国国立医学図書館（NLM）

Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT)

This study delves into the long-term visual outcomes of patients participating in the [Comparison of Age-Related Macular Degeneration (AMD) Treatments Trials (CATT)]. The researchers analyzed the association of [baseline characteristics] and [early vision response] with visual outcomes at 1 and 2 years. Their findings provide valuable insights into the factors that influence the effectiveness of treatment for AMD, a leading cause of vision loss in older adults.

Predicting Long-Term Vision Outcomes in AMD

The study identified several factors that were predictive of [less visual acuity gain] at 2 years, including [older age], [larger choroidal neovascularization area], and [presence of geographic atrophy]. These findings underscore the importance of considering these factors when developing treatment strategies for AMD. The study also found that [early vision response] was a better predictor of 2-year outcomes than baseline characteristics. This information can help physicians identify patients who may benefit from early adjustments to their treatment regimen.

Navigating the Landscape of AMD Treatment

This research provides valuable insights into the treatment of [AMD]. The study's findings emphasize the importance of [individualized treatment] tailored to the patient's specific needs and early vision response. This information is crucial for developing effective treatment strategies that maximize visual outcomes and improve the quality of life for patients with AMD.

Dr. Camel's Conclusion

AMD is a challenging condition that can impact vision and quality of life. This research provides important insights into the factors that influence treatment outcomes. Like a camel navigating a shifting desert landscape, physicians must adapt their treatment strategies to individual patients, leveraging early vision response and considering key baseline characteristics to ensure the best possible visual outcomes.

Date :
  1. Date Completed 2016-03-17
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

26383996

DOI: Digital Object Identifier

NIHMS723479

Related Literature

Article Analysis
・Effective treatment of macular degeneration
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.